News

Mycoplasma genitalium macrolide resistance in QLD

  The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations …

Continue Reading

SpeeDx Awarded A$2.5 million by NSW Medical Devices Fund

SpeeDx Pty. Ltd. are among the recipients of the New South Wales Medical Devices Fund (MDF) 2017-2018, announced last night. …

Continue Reading

SpeeDx and Cepheid Announce European Distribution Partnership

Strategic commercial partnership in key European markets with Cepheid. SYDNEY, AUSTRALIA–(Marketwired – Jun 8, 2017) – SpeeDx Pty, Ltd., a …

Continue Reading

SpeeDx and Thermo Fisher Scientific Strategic Partnership

SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic. ResistancePlus™ MG Test would bring disease …

Continue Reading

Prospective Evaluation Study for ResistancePlus™ MG

  A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus™ MG assay against 1089 symptomatic …

Continue Reading

Nature Reviews Urology|Growing threat of macrolide resistant M. genitalium infections.

The authors of the review, Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium, published in Nature Review Urology recommended that …

Continue Reading

The Age | Researchers raise concerns over sexually transmitted superbug

This drug-resistant sexually transmitted infection is behaving like a superbug and researchers estimate as many as 400,000 Australians may be …

Continue Reading

Evaluation of SpeeDx PlexPrime™ and PlexZyme™ technology published in PLOS One

SpeeDx Pty. Ltd. announced the publication of a novel technology, ‘Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection …

Continue Reading

SpeeDx Receives TGA Approval For ResistancePlus™ MG

Mycoplasma genitalium (MG) is one of the fastest growing STIs in the world and has been reported to have a …

Continue Reading

Evaluation of SpeeDx’s CE-marked ResistancePlus™ MG test for M. genitalium published in Journal of Clinical Microbiology

ResistancePlus™ MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection. SpeeDx …

Continue Reading